Biomarker identifies men with prostate cancer who may benefit from chemotherapy
2 monthes ago - By Healio
A validated assay for detecting nuclear-localized androgen receptor splice variant 7 protein in circulating tumor cells identified men with prostate cancer who lived longer with taxane chemotherapy than with an androgen receptor signaling inhibitor, according to results of a multi-institutional cohort study.
“The test should be considered for patients for whom increased OS is an objective,” Howard I. Scher, MD, co-chair of the Center for Mechanism Based Therapy and head of the Biomarker Development Initiative at Memorial Sloan Kettering Cancer Center, and colleagues wrote. “For
Read more ...
The headlines of Master Doctor
Blasting prostate tumours with radiotherapy CAN increase the chances of survival
Targeting the source of advanced prostate cancer with radiotherapy after the disease has spread could increase the patient's chances of survival by 11 per cent.
Chronic Inflammation Linked to Increased Alzheimer's Disease Risk
ApoE4 gene carriers who have chronic inflammation are more likely to develop Alzheimer's disease, finds a new study.
Blood Biomarker Distinguishes Parkinson's from MSA
Alpha-synuclein levels in brain-derived exosomes highlight differences
Tapping Into Telehealth
Title: Tapping Into Telehealth Category: Health News Created: 10/22/2018 12:00:00 AM Last Editorial Review: 10/22/2018 12:00:00 AM
VIDEO: The Ocular Surface: Critical for Refractive Cataract Surgery Success
NEW YORK - From OSN New York 2018, Darrell White, MD, founder of SkyVision Centers in Westlake, Ohio, gives his presentation on how the ocular surface is critical for...
Patient Outcomes of Prostate Cancer with Whole Slide Imaging
An interview with Dr. Anil Parwani, discusses how whole slide imaging of prostate cancer sections is helping to inform pathologists and improve patient outcomes.
Patient-reported data confirms efficacy of brachytherapy alone in...
Oncology trial RTOG 0232 comparing a combined treatment of external beam therapy and brachytherapy to transperineal interstitial permanent brachytherapy alone indicate a...
Nearly 90% Free of Prostate Ca Progression With ADT, Pelvic Node RT
Data also showed trend toward reduction in distant metastases
Prostate RT Ups Overall Survival in Metastatic Disease
Benefit limited to men with low disease burden
Biomarker May Distinguish Parkinson's From MSA
Alpha-synuclein in brain-derived blood exosomes is a potential biomarker that allows Parkinson's disease to be more easily distinguished from multiple system atrophy . Medscape...